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Long chain alkyl hydroxycinnamates (8e21) were synthesized from the corresponding half esters of malonic acid 
(5e7) and benzaldehyde derivatives by Knoevenagel condensation. The total antioxidant capacity of these 
hydroxycinnamyl esters was evaluated using DPPH and ABTS assays. The observed antioxidant activity was highest 
for esters of caffeic acid followed by sinapic esters and ferulic esters. The parameters for drug-likeness of these 
hydroxycinnamyl esters were also evaluated according to the Lipinski’s ‘rule-of-five’. All the ester derivatives were 
found to violate one of the Lipinski’s parameters (cLogP >5), even though they have been found to be soluble in protic 
solvents. The predictive topological 
polar surface area (TPSA) data allow concluding that they could have a good capacity for penetrating cell 
membranes. Therefore, one can propose these novel lipophilic compounds as potential antioxidants for tackling 
oxidative processes. 
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1. Introduction 
 
Phenolic acids, especially hydroxycinnamic acids, such as p-coumaric, 
ferulic, caffeic and sinapic acids, are natural hydrophilic antioxidants which 
occur in fruits, vegetables, spices and herbs. Hydroxyl groups present on 
cinnamic acids are often associated with their antioxidant activity. [1]. 
Hydroxycinnamic acids are of particular interest because of their potential 
biological outline dis- playing antioxidant, chelating, free radical scavenging, 
antiallergic, anti-inflammatory, antimicrobial, antiviral, anticarcinogenic 
and UV filter properties [1]. However these types of phenolic acids have 
relatively low solubility in aprotic media. The hydrophilic character of 
these antioxidants reduces their effectiveness in stabilizing lipophilic 
systems, such as fats and oils and has been reported as a serious 
disadvantage if an aqueous phase is also present. The hydrophobicity of 
phenolic acids can be enhanced by chemical esterification of the carboxyl 
group of the phenolic acid with a fatty alcohol to obtain an amphiphilic 
molecule, which should keep its original functional properties and 
therefore, extend the putative applications  of  these  natural  
antioxidants  in  oil  based  food 
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processing and cosmetics. [1]. Long chain alkyl cinnamates isolated from 
Sophora flavescens have been shown to be free radical scav- engers [2]. 
The antioxidant activity of radish sprout (Raphanus sativus L) has been 
attributed to be related mainly with the presence of sinapic acid esters [3]. 
Similarly, esters of long chain alcohols with caffeic acid, isolated from 
Hypericum laricifolium have been shown to inhibit COX-1 enzymes [4]. 
Esters of sinapic and ferulic acids with alkanols have  been also used  in 
commercial applications  as sunscreens [5,6]. Recently, the occurrence of a 
relationship between the redox potentials and the antioxidant activity 
of hydroxycin- namic acids and derivatives has been demonstrated [7]. 
In this context, this work reports the design and synthesis of a new set 
of synthetic long chain alkyl cinnamyl esters using natural cinnamic acids as 
templates. In addition, the antioxidant activity of the hydroxylated long 
chain alkyl cinnamates and their precursors was studied along with the 
evaluation of their drug-likeness profile. 
 
2. Results and discussions 
 
2.1. Chemistry 
 
Long chain alkyl cinnamates have been previously prepared by using 
the appropriate cinnamic acid [8,9] or acid chloride [10] and the suitable 
long chain alkanol. This type of study was only 
 
 
 
conducted for identification purposes of the corresponding natural 
cinnamyl esters. However the synthetic procedures reported so far involve 
protection and deprotection steps, operations that conduct in general to 
low to moderate yields [8,9]. So, herein a novel synthetic strategy is 
presented in which the synthesis of long chain alkyl cinnamates 8e21 was 
performed by using monomalonates 5e7 and substituted benzaldehyde 
derivatives as starting material and applying the Verley-Doebner 
modification of Knoevenagel condensation reaction [11,12] (Scheme 1). 
Monomalonates were obtained in high yields by simply heating 
Meldrum’s acid (2, 2-dimethyl-1, 3-dioxane-4, 6-dione) 4 with 
alcohols in toluene [11,13]. The half esters of malonic acid 5e7 were obtained 
by refluxing tetradecanol (1), hexadecanol (2) and octa- decanol (3) with 
Meldrum’s acid 4. Half esters of malonic acid 5, 6 and 7 are new 
compounds and were fully characterized on the basis 
Table 1 
Long chain alkyl cinnamyl esters (8e21). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reference 
[9] 
# 
of their spectral data (FT-IR, 1H & 13C NMR and HRESIMS). 
Further condensation of monomalonates 5e7 with proto- 
catechualdehyde, vanillin, syringaldehyde, 4-hydroxybenzaldehyde, 4-
methoxybenzaldehyde, veratraldehyde, and benzaldehyde in the presence 
of dry pyridine and b-alanine was performed through a Verley-Doebner 
modification of Knoevenagel condensation [12] giving alkyl cinnamates 
(8e21) (see Table 1) in good yields ranging from 85% to quantitative. The 
long chain alkyl cinnamates 9,12 and 14 are new compounds, characterized by 
detail spectral data (FT-IR, 1H& 13C NMR and HRESIMS) and reported in the 
experimental section whereas the known compounds (8, 10, 11, 13, 
15e21) were charac- terized by spectral data and compared with literature 
reports. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Quant.-Quantitative, N-New. 
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[24] 
N 
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2.2. Evaluation of the total antioxidant capacity (TAC) of 
the cinnamic derivatives 
 
Total antioxidant capacity (TAC) assays have been often used to 
determine the hierarchy of radical-scavenging abilities of potential 
phenolic antioxidant compounds that work either through elec- 
 
(Table 2) [7,16]. In the same series the lipophilic esters exhibit 
approximately the same antioxidant performance. 
According to the data obtained in the ABTS assay, only caffeic acid and 
its esters disclose an antioxidant activity similar to that presented by 
Trolox. The results obtained are in good agreement with the expected 
activities of this type of phenolic systems since it was described that the 
ability of an antioxidant to scavenge the 
 þ 
tron- or H- donating mechanisms [14,15]. Accordingly, DPPH  artificial long-lived radical monocation ABTS depend on the 
(2,20-diphenyl-1-picrylhydrazyl radical) and ABTS þ (2,20 -azinobis- (3-
ethylbenzothiazoline-6-sulfonic acid)) assays were used to assess 
the radical-scavenging ability of hydroxycinnamic ester derivatives 
(Table 2). Out of the 10 hydroxycinnamic esters only compounds 8, 10, 
11, 12, 13, 18, 19 and 20 were evaluated for antioxidant activity 
since esters 15 and 16 were isolated from natural sources and have 
been evaluated earlier [2]. The TEAC values of the compounds under 
study obtained from the ABTS þ decolourization assay are presented in 
Table 2. The radical-scav- 
enging ability was only determined for the most outstanding 
antioxidants (based on DPPH data). Trolox, the water-soluble vitamin 
E analogue, was used as standard. 
The radical-scavenging ability data obtained for hydroxycin- namic 
esters against DPPH were in good agreement with the expected 
activities of this type of phenolic systems: it is higher when a catechol 
group is present (caffeic series), and lower when the meta-hydroxyl 
function is substituted by a methoxyl group (ferulic series), having 
the sinapic series intermediate values 
resonance stabilization energy of the phenoxyl radical species [16]. 
The antiradical properties obtained for the known hydroxycin- namic 
derivatives (8, 10) compare well with published values [9,16e19]. 
Moreover, the ABTS results follow the same tendency, although not as 
noticeable, verified from the results obtained with the DPPH method. 
 
2.3. Calculation of drug-likeness properties 
 
Drug-likeness can be deduced as a delicate balance among the 
molecular properties of a compound that directly influence its 
pharmacodynamics and pharmacokinetics and ultimately affect their 
absorption, distribution, metabolism, and excretion in human body like a 
drug [20]. In general, these parameters allow to ascertain a poor oral 
absorption, or membrane permeability, that occurs when the evaluated 
molecules present values higher than five H-bond donors (HBD), 10 H-
bond acceptors (HBA), molecular weight (MW) > 500 Da and LogP 
(cLogP) > 5 (Lipinski’s ‘rule-of-five’) [21]. 
Cinnamates R1 R2 R3 R4 Yield % 
8 C14H29 H OH H 95 
9 C14H29 H OCH3 H 95 
10 C14H29 OH OH H 91 
11 C14H29 OCH3 OH H Quant.# 
12 C14H29 OCH3 OH OCH3 85 
13 C16H33 OH OH H Quant. 
14 C16H33 OCH3 OCH3 H 88 
15 C16H33 OCH3 OH H Quant. 
16 C16H33 OCH3 OH OCH3 94 
17 C16H33 H H H 95 
18 C18H37 OH OH H 89 
19 C18H37 OCH3 OH H 97 
20 C18H37 OCH3 OH OCH3 93 
21 C18H37 H H H 95 
 
  
 
 
 
Scheme 1. Synthesis of long chain alkyl cinnamates 8e21 from monomalonates 5e7. 
 
Table 2 
Structural properties of the phenolic acids and derivatives under study.a 
 
 
TPSA DPPH IC50 (mm) ABTS þb Molecular weight miLogPa n-ROTB n-ON acceptors n-ONNH donors Volume TPSA 
 
 
p-coumaric acid >100 ec 
8 >100 ec 
 
Caffeic acid 34.1 0.95 180.16 0.94 2 4 3 154.50 77.76 
10 31.9 0.98 376.54 8.05 16 4 2 390.45 66.76 
13 33.0 0.96 404.59 8.72 18 4 2 424.05 66.76 
18 38.0 1.02 432.64 9.12 20 4 2 457.66 66.76 
 
Ferulic acid 111.6 1.76 194.19 1.25 3 4 2 172.02 66.76 
11 110.2 1.66 390.56 8.30 17 4 1 407.97 55.77 
19 117.0 1.80 446.67 9.22 21 4 1 475.18 55.77 
 
Sinapic acid 66.0 1.14 224.21 1.26 4 5 2 197.57 75.99 
12 77.2 1.18 420.59 8.32 18 5 1 433.52 65.00 
20 77.1 1.16 476.70 9.22 22 5 1 500.73 65.00 
 
a  n-ROTB, number of rotatable bonds; n-OHNH, number of hydrogen bond donors; n-ON, number of hydrogen acceptors; TPSA, topological polar surface area. 
b  mmol AH equivalent to 1 mmol Trolox. 
c  not determined. 
 
However, it is important to note that there are many violations of this rule 
among existing drugs and vice versa, and therefore, qualifying the “rule of 
five” does not guarantee that a molecule is “drug-like” [20]. Topological 
polar surface area (TPSA) is now been recognized as a good indicator of 
drug absorbance in the intestines, Caco-2 monolayers penetration, and 
bloodebrain barrier crossing [22]. 
The mentioned parameters were calculated for the hydroxycin- namic 
esters in analysis and the results are depicted in Table 2. From the data 
obtained, one can notice that the phenolic acids are not able to cross membranes 
effectively, once they have a logD 1. The alkyl cinnamic esters possess an 
adequate number of proton acceptor and proton donor groups to ensure 
efficient interaction with the hydrogen- bonding groups of the receptors. 
Hydrogen-bonding capacity has been also identified as an important 
parameter for describing drug permeability [20,21]. All the ester derivatives 
were found to violate one of the Lipinski’s parameters (logP (cLogP) > 5), 
although they have 
been found to have solubility in protic solvents. Accordingly to their 
predictive TPSA data it seems that this type of cinnamic esters could have a 
good capacity for penetrating cell membranes. 
 
3. Experimental section 
 
3.1. General 
 
Meldrum’s acid was prepared according to literature procedure [23]. 
Melting points were recorded using Thiele tube and are uncor- rected. UV 
spectra were recorded on a Shimadzu UV-2450 UVeVisible 
spectrophotometer. IR spectra were recorded as KBr diluted pellets on a 
Shimadzu (IR Prestige-21) FTIR spectrophotometer. 1H and 13C NMR spectra 
were recorded at 300 and 75 MHz, respectively on a Bruker 
WT 300 FT-NMR instrument with TMS as internal standard. Chemical shifts 
are recorded in d values and coupling constant (J) are given in Hz. The 
multiplicities of carbon signals were obtained from dis- tortionless 
enhancement by polarization transfer (DEPT). High reso- lution mass 
spectra (HRMS-ESIþ) were performed on a microTOF (focus) mass 
spectrometer. Ions were generated using an ApolloII (ESI) source. 
Ionization was achieved by electrospray, using a voltage of 4500 V applied to 
the needle, and a counter voltage between 100 and 150 V applied to the 
capillary. All yields refer to isolated products unless stated otherwise. 
 
3.2. Synthesis of half esters of malonic acid (5e7) 
 
Equimolar quantities (10 mmol) of appropriate alcohols 1e3 and 
Meldrum’s acid 4 were refluxed in toluene (5 mL) for 4 h. The reaction 
was cooled to room temperature and then extracted with saturated NaHCO3 
solution. The bicarbonate layer was neutralized with conc. HCl to release the 
half esters of malonic acid, which were extracted with diethyl ether, washed 
with water, dried over anhy- 
drous Na2SO4 and evaporated to yield pure half esters of malonic acid 5e7. 
 
3.2.1. Monotetradecyl malonate (5) 
Colorless solid; yield 95%; m.p. 45 C (Petroleum ether); IR (KBr, cm 1): 
3225e3500, 2918, 1744 (ester CO), 1692 (acid CO), 1284, 1166, 825; 1H NMR (300 
MHz, CDCl3) d: 0.88 (t, J ¼ 6.6 Hz, 3H, H-140 ), 1.26 (bs, 22H, H-30 -130 ), 1.65 
(m, 2H, H-20 ), 3.43 (s, 2H, H-2), 4.17 
(t, J ¼ 6.6 Hz, 2H, H-10); 13C NMR (75 MHz, CDCl3) d: 14.1 (C-140), 22.7 (C-130 ), 
25.8 (C-30 ), 28.4(C-20), 29.3 (C-40 , 110), 29.6 (C-50-100), 31.9 
(C-120 ), 40.5 (C-2), 65.7 (C-10 ), 167.3 (C-3), 170.6 (C-1); HRESIMS: m/z 
323.2195 (M þ Na)þ; Calcd for C17H32O4Naþ: 323.2198. 
3.2.2. Monohexadecyl malonate (6) 
Colorless solid; yield 90%; m.p. 59 C (Petroleum ether); IR (KBr, cm 1): 
2400e3600, 1744 (ester CO), 1695 (acid CO), 1283, 1166, 750; 1H NMR (300 
MHz, CDCl3) d: 0.88 (t, J ¼ 6.6 Hz, 3H, H-160 ), 1.26 (bs, 
26H, H-30-150), 1.67 (m, 2H, H-20 ), 3.45 (s, 2H, H-2), 4.20 (t, J ¼ 6.6 Hz, 
2H, H-10); 13C NMR (75 MHz, CDCl3) d: 14.1 (C-160), 22.7 (C-150), 25.7 
(C-30), 28.4 (C-20 ), 29.3 (C-40 , 130), 29.7 (C-50 -120 ), 31.9 (C-140 ), 40.6 
(C-2), 65.7 (C-10 ), 167.2 (C-3), 170.9 (C-1); HRESIMS: m/z 351.2516 
(M þ Na)þ; Calcd for C19H36O4Naþ: 351.2511. 
3.2.3. Monooctadecyl malonate (7) 
Colorless solid; yield 96%; m.p. 65 C (Petroleum ether); IR (KBr, cm 1): 
2400e3600, 1745 (ester CO), 1693(acid CO), 1284, 1166, 750; 1H NMR (300 
MHz, CDCl3) d: 0.88 (t, J ¼ 6.6 Hz, 3H, H-180 ), 1.26 (bs, 
30H, H-30 -170), 1.69 (m, 2H, H-20), 3.44 (s, 2H, H-2), 4.19 (t, J ¼ 6.6 Hz, 
2H, H-10 ); 13C NMR (75 MHz, CDCl3) d: 14.1 (C-180), 22.7 (C-170 ), 25.7 
(C-30), 28.4 (C-20), 29.3 (C-40 , 150 ), 29.7 (C-50-140 ), 31.9 (C-160 ), 40.5 
(C-2), 65.7 (C-10), 167.3 (C-3), 170.3 (C-1); HRESIMS: m/z 379.2827 
(M þ Na)þ; Calcd for C21H40O4Naþ: 379.2824. 
164.16 1.43 2 3 2 146.48 57.53 
360.54 8.43 16 3 1 382.43 46.53 
 
 
 
3.3. Synthesis of long chain alkyl cinnamates (8e21) 
 
Equimolar quantities (2 mmol) of the appropriate half ester of malonic 
acid and the appropriate benzaldehyde derivative along with dry 
pyridine (1.0 mL) and b-alanine (12e15 mg) were refluxed for 90e110 min. 
For hydroxybenzaldehydes the reaction mixtures were kept at room 
temperature in Erlenmeyer flasks with loosely fitted bar corks for 2 
weeks. Reaction mixture was cooled in an ice bath and conc. HCl (1.0 mL) 
was added. Extraction with diethyl ether or filtration on a Buchner 
funnel afforded the crude cinna- mates, 8e21 which were further 
purified by recrystallization. 
 
3.3.1. Trans-tetradecyl-3-(4-hydroxyphenyl) propenoate (8) 
Colorless solid; m.p. 89 C (methanol) (lit. [9] 88e90 C); HRE- SIMS: 
m/z 383.2554 (M þ Na)þ; Calcd for C23H36O3Naþ: 383.2557. 
Identical with ref [9]. 
 
3.3.2. Trans-tetradecyl-3-(4-methoxyphenyl) propenoate (9) 
Colorless solid; m.p. 51 C  (methanol);  UV  (MeOH):  309, 226 nm; IR 
(KBr, cm 1): 2916, 1707 (CO), 1606, 1517, 1182, 825; 1H NMR (300 MHz, 
CDCl3) d: 0.88 (t, J ¼ 6.6 Hz, 3H, H-140), 1.26 (bs, 
22H, H-30-130), 1.69 (m, 2H, H-20), 3.84 (s, 3H, OCH3), 4.18 
(t, J ¼ 6.6 Hz, 2H, H-10 ), 6.31 (d, J ¼ 15.9 Hz, 1H, H-2), 6.90 
(d, J ¼ 8.8 Hz, 2H, H-6, 8), 7.48 (d, J ¼ 8.8 Hz, 2H, H-5, 9), 7.64 (d, J ¼ 
15.9 Hz, 1H, H-3); HRESIMS: m/z 397.2704 (M þ Na)þ; Calcd for 
C24H38O3Naþ: 397.2713. 
 
3.3.3. Trans-tetradecyl-3-(3,4-dihydroxyphenyl)propenoate   (10) 
Colorless solid; m.p. 106 C (methanol) (lit [9,24]. 108e109 C); 
HRESIMS: m/z 399.2508 (M þ Na)þ; Calcd for C23H36O4Naþ: 399.2506. 
Identical with ref [9] and [24]. 
 
3.3.4. Trans-tetradecyl-3-(4-hydroxy-3-methoxyphenyl) 
propenoate  (11) 
Colorless solid; m.p. 70 C (methanol) (lit [25]. 76 C); identical with ref 
[25]. 
 
3.3.5. Trans-tetradecyl-3-(3,5-dimethoxy-4-hydroxyphenyl) 
propenoate  (12) 
Colorless solid; m.p. 62 C (methanol); UV (MeOH): 327, 240 nm; IR (KBr, cm 
1): 3554 (OH), 2917, 1709 (CO), 1639, 1516, 1181, 843; 1H NMR (300 MHz, CDCl3) d: 
0.87 (t, J ¼ 6.6 Hz, 3H, H-140 ), 1.25 (bs, 22H, H-30- 
130 ), 1.69 (m, 2H, H-20 ), 3.91 (s, 6H, 2  OCH3), 4.18 (t, J ¼ 6.6 Hz, 2H, H- 
10), 5.81 (s, 1H, OH), 6.30 (d, J ¼ 15.9 Hz, 1H, H-2), 6.77 (s, 2H, H-5, 9), 
7.58 (d, J ¼ 15.9 Hz, 1H, H-3); 13C NMR (75 MHz, CDCl3) d: 14.1 (C-140 ), 
22.7 (C-130), 25.9 (C-30), 28.8 (C-20 ), 29.2 (C-40 ), 29.3 (C-110), 29.6 (C-50 - 
100 ), 31.9 (C-120), 56.3 (2 OCH3), 64.6 (C-10), 105.1 (C-5, 9), 116.1 (C-2), 
 
126.0 (C-4), 137.1 (C-7), 144.8 (C-3), 147.2 (C-6, 8), 167.2 (C-1); HRE- SIMS: m/z 
443.2762 (M þ Na)þ; Calcd for C25H40O5Naþ: 443.2768. 
3.3.6. 3.3Trans-hexadecyl-3-(3,4-dihydroxyphenyl)propenoate   (13) 
Colorless solid; m.p. 102 C (methanol) (lit [24]. 110e111 C); UV (MeOH): 
329, 219 nm; IR (KBr, cm 1): 3481 (OH), 3312 (OH), 2918, 
1684 (CO), 1606, 1286, 1180, 974, 815; 1H NMR (300 MHz, CDCl3) d: 
0.87 (t, J ¼ 6.6 Hz, 3H, H-160 ), 1.25 (bs, 26H, H-30 -150 ), 1.67 (m, 2H, 
H-20), 4.18 (t, J ¼ 6.75 Hz, 2H, H-10), 5.69 (bs, 2H, 2   OH), 6.27 
(d, J ¼ 15.9 Hz, 1H, H-2), 6.87 (d, J ¼ 8.1 Hz, 1H, H-8), 7.02 (dd, J ¼ 8.1, 
1.8 Hz, 1H, H-9), 7.09 (d, J ¼ 1.8 Hz, 1H, H-5), 7.57 (d, J ¼ 15.9 Hz, 1H, 
H-3); 13C NMR (75 MHz, DMSO-d6) d: 13.4 (C-160 ), 21.6 (C-150 ), 24.9 
(C-30), 27.7 (C-20), 28.1 (C-40 , 130), 28.5 (C-50-120), 30.8 (C-140), 63.2 
(C-10), 113.5 (C-2), 114.3 (C-8), 115.2 (C-5), 120.8 (C-9), 125.0 (C-4), 
144.5 (C-6), 145.1 (C-3), 147.9 (C-7), 166.1 (C-1); HRESIMS: m/z 
427.2815 (M þ Na)þ; Calcd for C25H40O4Naþ: 427.2819. 
3.3.7. Trans-hexadecyl-3-(3,4-dimethoxyphenyl)  propenoate  (14) 
Colorless solid; m.p. 67 C (methanol); UV (MeOH): 322, 295, 235, 218 
nm; IR (KBr, cm 1): 2916, 1720 (CO), 1514, 1271, 976, 843; 
1H NMR (300 MHz, CDCl3) d: 0.87 (t, J ¼ 6.6 Hz, 3H, H-160), 1.25 (bs, 
26H, H-30-150), 1.69 (m, 2H, H-20), 3.91 (s, 6H, 2    OCH3), 4.18 
(t, J ¼ 6.6 Hz, 2H, H-10 ), 6.31 (d, J ¼ 15.9 Hz, 1H, H-2), 6.86 
(d, J ¼ 8.4 Hz, 1H, H-8), 7.05 (d, J ¼ 1.8 Hz, 1H, H-5), 7.10 (dd, J ¼ 8.1, 
1.8 Hz, 1H, H-9), 7.62 (d, J ¼ 15.9 Hz, 1H, H-3); HRESIMS: m/z 
455.3149 (M þ Na)þ; Calcd for C27H44O4Naþ: 455.3132. 
 
3.3.8. Trans-hexadecyl-3-(4-hydroxy-3-methoxyphenyl) 
propenoate  (15) 
Colorless solid; m.p. 69 C (methanol) (lit [26,2]. 61e63 C); identical 
with ref [26] and [2]. 
 
3.3.9. Trans-hexadecyl-3-(3,5-dimethoxy-4-hydroxyphenyl) 
propenoate  (16) 
Colorless solid; m.p. 60 C (methanol); HRESIMS: m/z 471.3078 (M þ 
Na)þ; Calcd for C27H44O5Naþ: 471.3081. Identical with ref [2]. 
 
3.3.10. Trans-hexadecyl-3-phenylpropenoate   (17) 
Colorless solid; m.p. 38 C (Petroleum ether) (lit [27]. 39.6e40.6  
C); UV (MeOH): 276, 217 nm; IR (KBr, cm 1): 2924, 
1717 (CO), 1638, 1310, 1167, 766; 1H NMR (300 MHz, CDCl3) d: 0.88 (t, J ¼ 6.6 
Hz, 3H, H-160 ), 1.25 (bs, 26H, H-30-150), 1.69 (m, 2H, H-20), 
4.20 (t, J ¼ 6.6 Hz, 2H, H-10), 6.44 (d, J ¼ 15.9 Hz, 1H, H-2), 7.37e7.53 
(m, 5H, Ar-H), 7.68 (d, J ¼ 15.9 Hz, 1H, H-3); 13C NMR (75 MHz, CDCl3) d: 
14.1 (C-160 ), 22.7 (C-150), 25.9 (C-30), 28.7 (C-20), 29.2 (C- 
40 ), 29.3 (C-130), 29.7 (C-50-120), 31.9 (C-140), 64.7 (C-10 ), 118.3 (C-2), 
128.0 (C-5, 9), 128.8 (C-6, 8), 130.2 (C-4), 134.5 (C-7), 144.5 (C-3), 
167.1  (C-1);  HRESIMS:  m/z  395.2924  (M  þ  Na)þ;  Calcd  for 
C25H40O2Naþ: 395.2921. 
 
3.3.11. 3.3.Trans-octadecyl-3-(3,4-dihydroxyphenyl) propenoate (18) 
Colorless solid; m.p. 108 C (methanol) (lit [24]. 110e112 C); UV (MeOH): 
328, 219 nm; IR (KBr, cm 1): 3481 (OH), 3311 (OH), 2918, 
1684 (CO), 1606, 1284, 1180, 974, 815; 1H NMR (300 MHz, DMSO-d6) 
d: 0.84 (t, J ¼ 6.6 Hz, 3H, H-180 ), 1.22 (bs, 30H, H-30 -170), 1.61 (m, 2H, 
H-20 ), 4.09 (t, J ¼ 6.45 Hz, 2H, H-10), 6.25 (d, J ¼ 15.9 Hz, 1H, H-2), 6.75 
(d, J ¼ 8.1 Hz, 1H, H-8), 7.0 (dd, J ¼ 8.1, 1.8 Hz, 1H, H-9), 7.04 
(d, J ¼ 1.8 Hz, 1H, H-5), 7.45 (d, J ¼ 15.9 Hz, 1H, H-3), 9.17 (s, 1H, OH), 
9.61 (s, 1H, OH); 13C NMR (75 MHz, DMSO-d6) d: 13.4 (C-180), 21.6 
(C-170 ), 24.9 (C-30), 27.8 (C-20), 28.2 (C-40, 150), 28.5 (C-50-140), 30.8 
(C-160), 63.2 (C-10 ), 113.5 (C-2), 114.2 (C-8), 115.2 (C-5), 120.8 (C-9), 
125.0 (C-4), 144.5 (C-3), 145.1 (C-6), 147.9 (C-7), 166.1 (C-1); HRE- SIMS: m/z 
455.3135 (M þ Na)þ; Calcd for C27H44O4Naþ: 455.3132. 
 
3.3.12. Trans-octadecyl-3-(4-hydroxy-3-methoxyphenyl) 
propenoate (19) 
Colorless solid; m.p. 104 C (methanol) (lit [28]. 110 C); identical with ref 
[28]. 
 
3.3.13. Trans-octadecyl-3-(3,5-dimethoxy-4-hydroxyphenyl) 
propenoate  (20) 
Colorless solid; m.p. 72 C (methanol) (lit [29]. 72e73 C); UV (MeOH): 
327, 236 nm; IR (KBr, cm 1): 3533 (OH), 2917, 1708 (CO), 
1638, 1516, 1181,  836;  1H  NMR  (300  MHz,  CDCl3)  d:  0.87 (t, J ¼ 6.6 
Hz, 3H, H-180 ), 1.25 (bs, 30H, H-30-170 ), 1.70 (m, 2H, H-20), 
3.92 (s, 6H, 2  OCH3), 4.19 (t, J ¼ 6.6 Hz, 2H, H-10), 5.78 (s, 1H, OH), 
6.30 (d, J ¼ 15.9 Hz, 1H, H-2), 6.77 (s, 2H, H-5, 9), 7.59 (d, J ¼ 15.9 Hz, 
1H, H-3); 13C NMR (75 MHz, CDCl3) d: 14.1 (C-180), 22.7 (C-170), 25.9 
(C-30 ), 28.8 (C-20 ), 29.2 (C-40), 29.3 (C-150 ), 29.7 (C-50-140), 31.9 
(C-160), 56.3 (2  OC H3), 64.6 (C-10), 105.1 (C-5, 9), 116.1 (C-2), 126.0 
(C-4), 137.1 (C-7), 144.8 (C-3), 147.2 (C-6, 8), 167.2 (C-1); HRESIMS: 
m/z 499.3398 (M þ Na)þ; Calcd for C29H48O5Naþ: 499.3394. 
3.3.14. Trans-octadecyl-3-phenylpropenoate   (21) 
Colorless solid; m.p. 45 C (petroleum ether) (lit [29]. 45e46 C); UV 
(MeOH): 276, 218 nm; IR (KBr, cm 1): 2920, 1713 (CO), 1639, 1311, 1175, 766; 1H 
NMR (300 MHz, CDCl3) d: 0.88 (t, J ¼ 6.6 Hz, 3H, H-180), 
1.26 (bs, 30H, H-30 -170 ), 1.69 (m, 2H, H-20), 4.20 (t, J ¼ 6.6 Hz, 2H, H- 
10 ), 6.44 (d, J ¼ 15.9 Hz, 1H, H-2), 7.37e7.55 (m, 5H, Ar-H), 7.68 (d, J ¼ 15.9 Hz, 
1H, H-3); 13C NMR (75 MHz, CDCl3) d: 14.1 (C-180 ), 22.7 (C-170 ), 25.9 (C-30), 
28.7 (C-20), 29.3 (C-40 ), 29.6 (C-150), 29.7 (C-50 - 
140), 31.9 (C-160), 64.7 (C-10), 118.3 (C-2), 128.0 (C-5, 9), 128.8 (C-6, 8),
  
 
 
 
 
130.2 (C-4), 134.5 (C-7), 144.5 (C-3), 167.1 (C-1); HRESIMS: m/z 
423.3235 (M þ Na)þ; Calcd for C27H44O2Naþ: 423.3233. 
3.4. Determination of antioxidant activity 
 
(i) The DPPH assay. Total antioxidant capacity assay was per- formed 
using DPPH as radical source. Radical-scavenging activity was 
spectrophotometrically evaluated in a Powerwave XS Micro- plate 
Reader (Bio-Tek Instruments, Inc) by monitoring the disap- pearance of 
1,1-diphenyl-2-picrylhydrazyl (DPPH) at 515 nm, as previously reported 
[14]. Increasing concentrations of the different hydroxy cinnamates, were 
prepared in duplicate, in ethanol. Each solution (20 mL) was added to 
180 mL of DPPH radical solution (0.1 mM) in a 96-well microplate and 
absorbances were recorded every minute for a 45 min period. The 
absorbance of a blank control (20 mL ethanol plus 180 mL of radical) 
was set as 100% of radical (0% bleaching). 
Radical-scavenging activity, expressed as the percentage of 
inhibition, was calculated according to the formula:  % Inhibition ¼ 
[(Acontrol  Asample)/Acontrol]   100, where Acontrol is the absorbance of 
the DPPH solution without the sample (blank control) and Asample is the 
absorbance of the tested hydrox- ycinnamate. IC50 values were 
calculated as the minimum concen- tration of each sample required to 
inhibit 50% of the DPPH radical. 
(ii) The ABTS þ assay. The radical-scavenging activity of tested 
compounds was measured by the Trolox equivalent antioxidant capacity 
(TEAC) assay, as previously described [15,16]. This method is based on the 
ability of hydrogen-donating antioxidants to decolorize the preformed 
radical monocation of 2,20 -azinobis-(3- ethylbenzothiazoline-6-sulfonic 
acid) (ABTS þ), generated by oxidation of ABTS with potassium 
persulfate. The ABTS þ solution was prepared by reaction of 10 mL of a 7 
mM aqueous ABTS solu- tion and 163 mL of a 150 mM (2.45 mM 
final concentration) potassium persulfate solution. After storage in the dark 
for 16 h, the radical cation solution was diluted in ethanol until the 
initial absorbance value of 0.7 0.04 at 734 nm was reached. Solutions of 0.5, 
1.0 and 1.5 mM for each cinnamic acid or ester were prepared 
(to achieve a 20e80% decrease in the initial absorbance of the reaction 
solution). An aliquot of the compound solution (20 mL) was added to 180 mL 
of the radical solution in a 96-well microplate. The decrease in absorbance 
was recorded at 0 and after 6 min. Anti- oxidant concentration  vs. % 
absorbance  reduction data were graphically plotted. The concentration 
of antioxidant giving the same percentage reduction of absorbance at 734 
nm as the 1 mM Trolox solution was calculated from the three-point graphs. 
 
3.4.1.  Data analysis 
Each experiment was performed in triplicate. Statistical 
comparisons of both assays were done by one-way ANOVA fol- lowed 
by the multiple Duncan test (P < 0.05). 
 
3.5.  Calculation of drug-likeness properties 
 
The parameters for drug-likeness were evaluated according to the 
Lipinski’s ‘rule-of-five’, using the Molinspiration WebME Editor 
1.16.  [http://www.molinspiration.com]. 
 
4. Conclusion 
 
Long chain alkyl hydroxy cinnamates (8e21) were synthesized from 
the corresponding half esters of malonic acid (5e7) and benzaldehyde 
derivatives by Knoevenagel condensation in good yields (85% to 
quantitative). The antioxidant activity of eight hydroxycinnamyl esters 
was studied using DPPH and ABTS assays. The radical-scavenging ability 
data obtained for hydroxycinnamic 
esters against DPPH and ABTS radicals were in good agreement with 
the expected activities of this type of phenolic systems as it has been 
demonstrated earlier [7]: it is higher when a catechol group is present 
(caffeic series), and lower when the meta-hydroxyl function is substituted 
by a methoxyl group (ferulic series), having the sinapic series with 
intermediate values. The esterification does not significantly modify the 
antioxidant activity of precursors, a fact that is in accordance with the main 
objective of the work. These novel agents have the advantage of being 
synthesized from natural products, while providing a value-added use 
for oil systems. Accordingly, they could be formulated into standard UV-
absorbing daily-wear cosmetic, hair and skin care and sunscreen 
formula- tions. Due to its antioxidant properties, lipophilicity and capacity of 
absorbing UVB radiation the dihydroxycinnamic derivatives could also be 
applied for topical formulations to treat erythema and/or other skin 
diseases. 
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